Thus, most cytoplasmic actin mutations found in multiple myeloma might influence myosin binding (or possibly other actin-binding proteins contacting the N-terminus), whereas mutations found in DLBCL are more likely to affect actin polymer formation or stability. Here, MYH14 is linked to diffuse large B-cell lymphoma.